MVF Monash IVF Group Limited
Healthcare · Diagnostics & Research
· website
· 892 employees
$0.73
52wk 0.57 – 0.90
Overall
41.2
Value
53.4
Growth
42.0
Health
18.7
Quality
18.7
Momentum
63.3
Dividend
60.5
Price
About Monash IVF Group Limited
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.
Price analytics
Returns
| 1 day | 0.0% |
| 1 week | -0.7% |
| 1 month | -7.0% |
| 3 months | 3.5% |
| 6 months | 8.9% |
| 1 year | 5.8% |
| 3 years | -41.7% |
Risk
| Volatility (1y ann.) | 56.3% |
| Beta vs ASX 200 | 0.98 |
| Sharpe (1y) | 0.27 |
| VaR 95% (1-day) | -3.3% |
| Max drawdown (1y) | -29.0% |
| Off 1-year high | -16.5% |
Technicals
| RSI(14) | 32 |
| vs 50DMA | 0.1% |
| vs 200DMA | 2.8% |
| Trend | Golden cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
53.4
Trailing P/E
10
Forward P/E
79
PEG ratio
—
EV / EBITDA
19
Price / Book
95
Price / Sales
97
Growth
42.0
Revenue growth (1y)
84
Revenue CAGR (3y)
—
EPS growth (1y)
0
EPS CAGR (3y)
—
Financial Health
18.7
Net debt / EBITDA
0
Interest coverage (EBIT/interest)
0
Current ratio
0
Debt / Equity
67
Quality (Profitability & Cash Flow)
18.7
Return on equity
16
Return on assets
25
Operating margin
16
Net margin
18
Cash conversion (OCF / net income)
—
Dividend / Income
60.5
Dividend yield (%)
57
Payout ratio
71
FCF dividend cover
52
Momentum
63.3
6-month return vs ASX 200
84
Price vs 200-day average
59
Price vs 50-day average
51
Position in 52-week range
50
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$286.38M
P/E (trailing)
36.75
P/E (forward)
13.57
EPS (trailing)
0.02
Dividend yield
3.4%
Payout ratio
63.2%
Beta
0.38
EV / EBITDA
16.91
Price / Book
1.15
ROE
3.3%
Operating margin
4.0%
Net margin
2.8%
Total cash
$8.84M
Total debt
$199.62M
Current ratio
0.67
Debt / Equity
0.79
Free cash flow
$6.84M
Avg volume
618,719
Latest annual results
(FY ending 30 Jun 2024)
- Revenue$254.96M
- Gross profit$228.35M
- Operating income-$5.61M
- Net income-$6.53M
- Diluted EPS-0.02
- Free cash flow$30.85M
- Net debt$124.04M